These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8103573

  • 1. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss.
    Srivastava R, Brouillet E, Beal MF, Storey E, Hyman BT.
    Neurobiol Aging; 1993; 14(4):295-301. PubMed ID: 8103573
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P, Langston JW, Di Monte DA.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [Abstract] [Full Text] [Related]

  • 4. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
    Wüllner U, Löschmann PA, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, Klockgether T.
    Neuroreport; 1996 Mar 22; 7(4):921-3. PubMed ID: 8724674
    [Abstract] [Full Text] [Related]

  • 5. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
    Chan P, Di Monte DA, Langston JW, Janson AM.
    J Pharmacol Exp Ther; 1997 Jan 22; 280(1):439-46. PubMed ID: 8996226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
    Turski L, Bressler K, Rettig KJ, Löschmann PA, Wachtel H.
    Nature; 1991 Jan 31; 349(6308):414-8. PubMed ID: 1846943
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD.
    Neurodegeneration; 1996 Sep 31; 5(3):265-74. PubMed ID: 8910905
    [Abstract] [Full Text] [Related]

  • 12. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S.
    Neurodegeneration; 1995 Sep 31; 4(3):257-69. PubMed ID: 8581558
    [Abstract] [Full Text] [Related]

  • 13. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU.
    J Neurochem; 1992 Aug 31; 59(2):733-9. PubMed ID: 1629743
    [Abstract] [Full Text] [Related]

  • 14. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M, Little MD, Bankiewicz K, Yang SC, Markey SP, Johannessen JN.
    Neuroscience; 1991 Aug 31; 40(1):133-58. PubMed ID: 2052148
    [Abstract] [Full Text] [Related]

  • 15. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
    Wu RM, Murphy DL, Chiueh CC.
    J Neural Transm Gen Sect; 1995 Aug 31; 100(1):53-61. PubMed ID: 8748663
    [Abstract] [Full Text] [Related]

  • 16. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
    Giustizieri M, Cucchiaroni ML, Guatteo E, Bernardi G, Mercuri NB, Berretta N.
    J Pharmacol Exp Ther; 2007 Aug 31; 322(2):721-9. PubMed ID: 17496164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 31; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J, Cheng FC, Yang Z, Dryhurst G.
    J Neurochem; 1999 Oct 31; 73(4):1683-95. PubMed ID: 10501216
    [Abstract] [Full Text] [Related]

  • 20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ, Dunnett SB, Northrop AJ, Morris BJ.
    Neuroscience; 1990 Oct 31; 37(3):757-66. PubMed ID: 2247221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.